Sambit Das News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Research Society for the Study of Diabetes in India (RSSDI) along with Sanofi India Limited (SIL) have shared that their collaboration for SIL’s social impact program for Type 1 diabetes (T1D) is delivering positive outcomes. The program has created

Sedentary lifestyle without any physical activities often leads to many diseases. However, as India currently harbours the second-largest population of people living with diabetes, the precursor to it, pre-diabetes, has become a concern across the nation. Pre-diabetes is a state just before

The trio bonded over books, not ones on Russia or Ukraine, and gorged on lip-smacking food from the stalls